CWM
Cahaba Wealth Management Portfolio holdings
AUM
$1.44B
1-Year Est. Return
12.72%
This Fund
S&P 500
1 Year Est. Return
+12.72%
AUM
$1.38B
AUM Growth
+$94.3M
(+7.3%)
Holding
164
Top Buys
| 1 | +$167M | |
| 2 | +$5.43M | |
| 3 | +$4.12M | |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$2.53M |
| 5 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$2.25M |
Top Sells
| 1 | +$151M | |
| 2 | +$8.41M | |
| 3 | +$1.32M | |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$977K |
| 5 |
Southern Company
SO
|
+$699K |
Sector Composition
| 1 | Utilities | 2.62% |
| 2 | Technology | 1.59% |
| 3 | Financials | 1.37% |
| 4 | Industrials | 0.54% |
| 5 | Healthcare | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amgen
AMGN
$209B
| $202K | 0.01% |
716
-140
|
|
||
152
Warner Bros
WBD
$69.9B
| $195K | 0.01% |
+10,002
|
|
||
|
FSCO
153
FS Credit Opportunities Corp
FSCO
$988M
| $191K | 0.01% |
27,682
+770
|
|
||
|
TGB
154
Taseko Mines
TGB
$3.24B
| $153K | 0.01% |
36,134
|
|
||
155
Nuveen Preferred & Income Opportunities Fund
JPC
$2.93B
| $99.3K | 0.01% |
+12,108
|
|
||
156
Galectin Therapeutics
GALT
$192M
| $88.9K | 0.01% |
21,000
|
|
||
157
FibroBiologics
FBLG
$21.9M
| $8.03K | ﹤0.01% |
14,702
|
|
||
158
Vanguard Total Bond Market
BND
$152B
| – | – |
-17,904
|
|
||
159
Emerson Electric
EMR
$84.7B
| – | – |
-1,664
|
|
||
160
Schwab US Dividend Equity ETF
SCHD
$85.3B
| – | – |
-16,018
|
|
||
161
Schwab US Aggregate Bond ETF
SCHZ
$10.1B
| – | – |
-22,454
|
|
||
162
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.5B
| – | – |
-5,867
|
|
||
163
Vanguard Mortgage-Backed Securities ETF
VMBS
$15B
| – | – |
-6,719
|
|
||
164
State Street Health Care Select Sector SPDR ETF
XLV
$42.5B
| – | – |
-1,842
|
|